Compare COCP & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COCP | AIRE |
|---|---|---|
| Founded | 2006 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1M | 11.5M |
| IPO Year | 2011 | 2023 |
| Metric | COCP | AIRE |
|---|---|---|
| Price | $1.07 | $1.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $6.00 | $1.30 |
| AVG Volume (30 Days) | 44.4K | ★ 59.7K |
| Earning Date | 05-15-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.65 | ★ 60.34 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,712,091.00 | $4,518,498.00 |
| Revenue This Year | N/A | $129.06 |
| Revenue Next Year | N/A | $83.72 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 376.42 |
| 52 Week Low | $0.76 | $0.16 |
| 52 Week High | $2.03 | $3.98 |
| Indicator | COCP | AIRE |
|---|---|---|
| Relative Strength Index (RSI) | 58.44 | 43.92 |
| Support Level | $0.99 | $0.29 |
| Resistance Level | $1.11 | $1.64 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 93.14 | 46.15 |
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.